INSIGHTS ON UPSTREAM MANUFACTURING
-
Advancing Perfusion Manufacturing For Cell And Gene Therapies
Perfusion and intensification reshaped mAb economics, and the same playbook is being tried on lentiviral vectors, CAR-T, NK cells, and iPSC platforms, where yields and variability limit scale.
-
A Simple, Scalable, And Reproducible Hydration Process For Biologics Production
A concentrated CHO feed can deliver strong fed-batch performance, yet its liquid form was once too unstable to sell, leaving users to hydrate powder and manage mixing time on their own.
-
Decoding Biologics Tech Transfer: Process Performance Across Sites And Scales
Explore how bioreactor modeling, equipment characterization, and process science can address scale-up challenges and maintain biologics performance across sites, scales, and bioreactor systems.
-
Set Your Own Intensity: When Economics Drives The Decision
Process intensification has no universal lowest-cost architecture. The right economic choice follows the manufacturing constraint, and it can shift as demand, scale, and productivity limits change.
-
Set Your Own Intensity: When Flexibility Matters Most11/13/2026
Intensifying one operation often shifts the constraint to another. Real flexibility depends on designing cadence, capacity, connections, and control, and on choosing how connected a workflow should be.
-
Set Your Own Intensity: When You Need More Speed11/13/2026
Going faster is not the same as making a process faster. Cutting time built into manufacturing means removing seed stages, holds, and recirculation, while confirming downstream steps can absorb the gain.
-
Set Your Own Intensity: When You Need More Output11/13/2026
Raising bioreactor output without adding vessel size means choosing between strategies, then confirming that harvest, capture, and purification can absorb the additional product.
-
Set Your Own Intensity: Rethink What Is Possible11/13/2026
Process intensification is a menu of strategies, not a single route. Starting from the constraint holding a process back, rather than from added capacity, shapes which level of change fits.
UPSTREAM MANUFACTURING SOLUTIONS
-
Successful targeted oncology programs combine biological engineering, potent compound synthesis, and efficient manufacturing to reduce complexity and speed clinical progress.
-
Bead-free activation of human T cells through biodegradable nanoparticles aims to protect cell health during expansion, with the reagent cleared by simple washing or centrifugation.
-
Cell expansion built around low seeding requirements and high yields in 1 L or less. A bioreactor design drawn from human biology aims to simplify scale-up.
-
De-risk biotech development with guaranteed tech transfer and process support. Safeguard your investment from cell line development through protein optimization.
-
Scaling adherent cell culture from flasks to multilayer systems depends on surface consistency, aseptic connections, and more. See how ultrasonic welding and retention hardware shape that path.